Evaluation of long-term safety of the anti-IgE antibody, omalizumab, in children with allergic asthma
Year: 2003
Type: article
Study design: Clinical Trial
Institutions: Mission Hospital, Novartis (United States)
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2041651163
